Category Archives: TB

Global Fund Board responds to Independent Review Panel reform recommendations

By on .

The following guest blog post is by David Bryden, the Stop TB Advocacy Officer at RESULTS. The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP).  The board stated […]

Congressional staff explore depths of HIV research at CDC Field Station in Kisian, Kenya

By on .

The following is a post from Center for Global Health Policy Officer Carol Bergman, who recently traveled to Kenya with a group of Capitol Hill staff from key Congressional offices with jurisdiction over global health funding or programs. We went to the U.S. Centers for Disease Control & Prevention (CDC) Kisian Field Station – about […]

Engaging Indian industry in TB diagnostic innovations

By on .

The following is a guest blog post by Drs. Madhukar Pai and Nora Engel. A recent conference at St. John´s Research Institute (SJRI) in Bangalore, India brought together for the first time more than 200 representatives from industry, government, donors, academia, civil society and the media to discuss what it takes to innovate in tuberculosis […]

Senate committee votes on global health funding for fiscal year 2012; global AIDS cut

By on .

The Senate Appropriations Committee agreed to provide $7.9 billion for global health programs for the 2012 fiscal year beginning October 1 – $810 million below what President Obama requested for these programs and about $75 million above current funding levels – according to a committee press release. For the second year in a row, the global AIDS budget has been cut – despite promising research findings that chart a way forward to cut the toll from the major infectious disease killer…

Children and Tuberculosis: Exposing a Hidden Epidemic

By on .

“Tuberculosis (TB) remains among the top ten killers of children worldwide, yet virtually no public or political attention is paid to TB as a children’s health issue,” and at least 1 million children became sick with TB in 2009. That’s according to a new issue brief released today by Advocacy to Control TB Internationally (ACTION), […]

Civil society orgs want more done on Xpert rapid TB test pricing in South Africa

By on .

Civil society groups remain unhappy with the price South Africa is paying for the GeneXpert MTB/RIF – a rapid diagnostic for tuberculosis (TB), multidrug-resistant TB (MDR-TB) and TB in HIV-infected individuals developed by molecular diagnostics company Cepheid. Representatives from the Treatment Action Campaign (TAC), The Treatment Action Group, The AIDS Rights Alliance of South Africa and Partners in Health called on Cepheid CEO John Bishop and Dr. Giorgio Roscigno of the Foundation for Innovative New Diagnostics (FIND) – the company that co-developed Xpert with Cepheid – to do more to make the test affordable in South Africa and to shed some light on the pricing and price negotiation process…